This groundbreaking technology has the potential to revolutionize the care of extremely premature babies, offering a transformative shift in pediatric health and neonatal care. It represents a remarkable engineering breakthrough aimed at a vulnerable population in dire need of innovation.

Acessa Health is a women’s health, venture-backed startup with a procedure for women suffering from symptomatic uterine fibroids. The Acessa procedure is a minimally invasive, outpatient treatment with laparoscopic radiofrequency ablation to preserve the uterus. Acquired by Hologic for $80MM upfront cash + three-year period of contingent payments.

Sold assets to Acessa Health.

Led largest business unit, vascular intervention, within a publically traded, cardiovascular medical device company. Acquired AngioScore Company in 2014 and Stellarex Drug Coated Balloon asset from Covidien in 2015. Then, Acquired by Philips.

Led initial global commercial effort for a startup with neurovascular aneurysm technologies. Acquired by Balt

Post-acquisition of Concentric, recruited by the president to a newly created position of global marketing and therapy development. Launched first available AIS Stent Retriever - TREVO in the U.S. and Europe.

Led global commercial organization for acute ischemic stroke (AIS) technologies. Launched first available, AIS Mechanical Clot Removal technology - MERCI and TREVO in the U.S., Japan and Europe. Acquired by Stryker.

After failed merger of JNJ/GDT, senior management at Cordis created a new position and recruited me from ABT/BSC. Led large sales organization, promoting market leading peripheral, carotid and coronary stents, balloons and accessories.

Served as functional Area VP of Sales (reporting to Endovascular Solutions business unit president) for peripheral and carotid stent business. Launched first available carotid stent in the U.S. Acquired by ABT/BSC.

Sold and eventually led a team promoting peripheral thrombus removal, foreign body retrieval and ASD technologies to interventional radiology, cardiology and vascular surgery. Microvena acquired by ev3.